Ministério da Saúde, Trabalho e Bem-Estar do Japão concede designação de medicamento órfão ao tagraxofusp para Neoplasia de Células Dendríticas Plasmocitoides Blásticas (NCDPB) FLORENÇA, Itália e NOVA IORQUE, 30 de agosto de 2023 /PRNewswire/ — A Menarini Group (“Menarini”), uma empresa…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.